Arrowhead Pharmaceuticals
ARWR
$22.00
Share price
-2.67%
Change (1 day)
-27.62%
Change (1 year)
Categories
Arrowhead Pharmaceuticals (ARWR) - Net assets
Net assets on the balance sheet as of December 2023 : $0.17 B
According to Arrowhead Pharmaceuticals
's latest financial reports the company has $0.17 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Arrowhead Pharmaceuticals - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-09-30 | $0.28 B | -31.36% |
| 2022-09-30 | $0.41 B | 2.33% |
| 2021-09-30 | $0.40 B | -11.47% |
| 2020-09-30 | $0.46 B | 89.23% |
| 2019-09-30 | $0.24 B | 156.23% |
| 2018-09-30 | $95.24 M | 17.77% |
| 2017-09-30 | $80.86 M | -14.9% |
| 2016-09-30 | $95.02 M | -13.32% |
| 2015-09-30 | $0.10 B | -33.96% |
| 2014-09-30 | $0.16 B | 544.98% |
| 2013-09-30 | $25.73 M | 192.15% |
| 2012-09-30 | $8.8 M | -29.89% |
| 2011-09-30 | $12.56 M | 55.53% |
| 2010-09-30 | $8.07 M | 66.29% |
| 2009-09-30 | $4.85 M | -60.51% |
| 2008-09-30 | $12.3 M | -53.5% |
| 2007-09-30 | $26.45 M | -16.29% |
| 2006-09-30 | $31.6 M | 12.81% |
| 2005-09-30 | $28.01 M | 149.57% |
| 2004-09-30 | $11.22 M | 690.7% |
| 2003-09-30 | $1.41 M | -191.56% |
| 2002-09-30 | $-1.56 M | 18.87% |
| 2001-09-30 | $-1.31 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $68.77 B | 39,490.36% | 🇺🇸 USA |
 Moderna
MRNA | $13.85 B | 7,875.18% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $0.70 B | 303.49% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -$0.23 B | -227.02% | 🇺🇸 USA |
 Inovio Pharmaceuticals INO | $0.11 B | -32.45% | 🇺🇸 USA |